Exelixis Inc (EXEL) Growth Rates Comparisons to Biotechnology & Pharmaceuticals Industry, Sector, Market. Sales, Income, EPS
CSIMarket Company Name, Ticker, Competitors, else..
 
Exelixis Inc   (NASDAQ: EXEL)
 

Exelixis Inc Growth Comparisons

Select each growth Category to receive further Information




Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

EXEL Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q2 MRQ) 10.63 % 5.15 % 8.91 % 10.9 %
Q / Q Revenue Growth (Q2 MRQ) 2.93 % -11.92 % -3.28 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q2 TTM) 9.23 % 5.66 % 7.98 % %
Sequential Revenue Growth (for 12 months ending Q2 TTM) 2.54 % 1.16 % 2.03 % 2.61 %
Revenue 5 Year Average Growth 18.63 % 8.2 % 8.65 % 10.59 %


EXEL's Growth Comparisons in II. Quarter 2026




Exelixis Inc improved it's Revenue by 10.63% year on year in the second quarter 2026, and outpaced the 5.15% growth in the Biotechnology & Pharmaceuticals industry, and 8.91% growth in the Healthcare sector.

Comparing the company's Revenue to the first quarter results, sales were higher by 2.93% . On the yearly basis, average annual sales growth for Exelixis Inc is 18.63%, while S & P 500's including only Businesses with the second quarter 2026 earnings, average annual sales growth is 10.59% over the past five years.

EXEL Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Product
-
-
Collaboration
-
-
Reportable
-
-
Product, Gross
-
-
Product, Sales Discounts and Allowances
-
-
License
-
-
Collaboration services revenues Collaborative arrangement with Takeda
-
-
United States
-
-
Europe
131.08 %
116.27 %
Japan
163.47 %
34.04 %
CABOMETYX
116.92 %
103.23 %
COMETRIQ
115.68 %
107.85 %
Total
10.63 %
2.93 %


Growth Rates of EXEL's Income in the second quarter 2026


EXEL Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q2 MRQ) 16.31 % 434.95 % 4.62 % 97.6 %
Sequential Operating Income Change (Q2 MRQ) -1.16 % -48.89 % 0.89 % 48.13 %
Y / Y Operating Income Growth (Q2 TTM) 38.84 % 954.66 % 30.73 % 40.67 %
Sequential Operating Income Growth (Q2 TTM) 3.72 % 230.06 % 4.82 % 20.86 %
Operating Income 5 Year Avg. Change 51.29 % -18.41 % 10.39 % 18.76 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q2 MRQ) 14.32 % -78.96 % -25.98 % 90.69 %
Sequential Income from Cont. Ops. Change (Q2 MRQ) -0.72 % - -66.16 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q2 TTM) 37.73 % -86.66 % 2.68 % 57.33 %
Sequential Income from Cont. Ops. Change (Q2 TTM) 3.75 % -59.21 % -5.02 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change 72.83 % -11.5 % 0.17 % -28.52 %

EXEL Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q2 MRQ) 14.32 % -78.9 % -26.26 % 90.69 %
Q / Q Net Income Growth (Q2 MRQ) -0.72 % -86.69 % -0.77 % 27.07 %
Y / Y Net Income Change (Q2 TTM) 37.6 % 103.06 % 15.51 % 57.33 %
Sequential Net Income Change (Q2 TTM) 3.24 % -7.95 % -6.72 % 18.65 %
Net Income 5 Year Avg. Growth 72.83 % -8.55 % 9.21 % 22.96 %

EXEL's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q2 MRQ) 25 % -82.2 % -25.98 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q2 MRQ) 4.94 % - -66.16 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q2 TTM) 53.27 % - - -
Sequential EPS from Cont. Ops. Change (Q2 TTM) 5.47 % - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth 11.17 % 49.32 % 0.17 % -28.52 %



EXEL EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q2 MRQ) 26.15 % -82.15 % -26.26 % -28.52 %
Q / Q EPS Net Growth (Q2 MRQ) 3.8 % -88.25 % -0.77 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q2 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q2 TTM) 5.67 % - - 4.93 %
EPS Net 5 Year Avg. Change 11.53 % -8.55 % 9.21 % 22.96 %



Exelixis Inc showed impressive 26.15% year on year rise in the second quarter to $0.82, despite the -82.15% inBiotechnology & Pharmaceuticals industry, Healthcare sector dropped -26.26%. Slow second quarter 2026 income per share, in Biotechnology & Pharmaceuticals industry and Healthcare sector, were portrayed in the Exelixis Inc results which underperformed overall market.

Comparing company's EPS to the first quarter results, income per share were higher by 3.8% . On the yearly basis, average annual income per share growth for Exelixis Inc is 11.53%, while S & P 500's including only the businesses with the second quarter 2026 Results, average annual income per share growth is 22.96% over the past five years.

EXEL Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q2 MRQ) 551.99 % 6160.46 % 48.49 % 48.62 %
Sequential Free Cash Flow Change (Q2 MRQ) 20.21 % -53.57 % -46.96 % 34.18 %
Y / Y Free Cash Flow Change (Q2 TTM) 55.48 % 14 % 18.61 % 60.27 %
Sequential Free Cash Flow Change (Q2 TTM) 27.76 % 16.85 % 5.39 % 15.75 %
Free Cash Flow 5 Year Avg. Change 37.43 % -14.51 % 0.92 % 8.28 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q2 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q2 MRQ) - 36.63 % - 216.68 %
Y / Y Net Cash Flow Change (Q2 TTM) - 784.84 % - 209.43 %
Sequential Net Cash Flow Change (Q2 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change 38.18 % 23.25 % 6.46 % 1.06 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q2 MRQ) 140.17 % 32.26 % 8.23 % 120.03 %
Sequential Capital Expenditures Change (Q2 MRQ) 351.69 % -1.95 % -22.09 % 36.87 %
Y / Y Capital Expenditures Change (Q2 TTM) -38.97 % -4.97 % 7.87 % 109.38 %
Sequential Capital Expenditures Change (Q2 TTM) 56.94 % 8.05 % 1.6 % 23.05 %
Capital Expenditures 5 Year Avg. Change -22.6 % 9.64 % 9.18 % 14.73 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Y/Y Annual




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.